Justin J. Brenden - 12 Dec 2022 Form 4 Insider Report for SiriusPoint Ltd (SPNT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Dec 2022, 15:01:13 UTC
Prior SEC filing
08 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sumair Sangha, Attorney-in-Fact for Justin J. Brenden
Filing notes and source

Key filing fact

Justin J. Brenden filed Form 4 for SiriusPoint Ltd (SPNT) on 14 Dec 2022.

Key facts

  • This page summarizes Justin J. Brenden's Form 4 filing for SiriusPoint Ltd (SPNT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Dec 2022, 15:01.

Change

  • Previous filing in this sequence was filed on 08 Apr 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPNT transaction

Common Shares

Award

Transaction value
$0
Shares
+20,325
Change %
+9.9%
Price
$0.000000
Shares after
225,702
Date
12 Dec 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 20,325 restricted share units granted under the SiriusPoint Ltd. 2013 Omnibus Incentive Plan that vest in equal annual installments on December 12, 2023 and December 12, 2024, based on continued employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .